Qlife Holding AB is a medical device company that seeks to revolutionize the clinical biomarker testing of whole blood by taking it out of the lab and into the homes of the people who needs it. The Egoo Home System is an integrated platform consisting of a small home device and disposable capsules, each of which tests for a specific biomarker. It provides a digital infrastructure for sharing the data with the patient's doctor, clinic or hospital via smartphone and computer.
2019
35
Last FY Revenue $9K
Last FY EBITDA -$3.1M
$3.2M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
In the most recent fiscal year, Qlife Holding achieved revenue of $9K and an EBITDA of -$3.1M.
Qlife Holding expects next 12-month revenue of XXX   and NTM EBITDA of XXX
See Qlife Holding valuation multiples based on analyst estimatesNTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
---|---|---|---|---|---|
Revenue | XXX | $9K | XXX | XXX | XXX |
Gross Profit | XXX | $8K | XXX | XXX | XXX |
Gross Margin | XXX | 87% | XXX | XXX | XXX |
EBITDA | XXX | -$3.1M | XXX | XXX | XXX |
EBITDA Margin | XXX | -33236% | XXX | XXX | XXX |
EBIT | XXX | -$3.2M | XXX | XXX | XXX |
EBIT Margin | XXX | -34700% | XXX | XXX | XXX |
Net Profit | XXX | -$5.8M | XXX | XXX | XXX |
Net Margin | XXX | -62900% | XXX | XXX | XXX |
Net Debt | XXX | $0.6M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Qlife Holding's stock price is SEK 2 (or $0).
Qlife Holding has current market cap of SEK 25.0M (or $2.6M), and EV of SEK 31.0M (or $3.2M).
See Qlife Holding trading valuation dataEV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
---|---|---|---|---|---|---|
$3.2M | $2.6M | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Qlife Holding has market cap of $2.6M and EV of $3.2M.
Qlife Holding's trades at 347.9x EV/Revenue multiple, and -1.0x EV/EBITDA.
Equity research analysts estimate Qlife Holding's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Qlife Holding's P/E ratio is not available.
See valuation multiples for Qlife Holding and 12K+ public compsLTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
---|---|---|---|---|---|---|
Market cap (current) | $2.6M | XXX | $2.6M | XXX | XXX | XXX |
EV (current) | $3.2M | XXX | $3.2M | XXX | XXX | XXX |
EV/Revenue | n/a | XXX | 347.9x | XXX | XXX | XXX |
EV/EBITDA | n/a | XXX | -1.0x | XXX | XXX | XXX |
EV/EBIT | n/a | XXX | -1.0x | XXX | XXX | XXX |
EV/Gross Profit | n/a | XXX | n/a | XXX | XXX | XXX |
P/E | n/a | XXX | -0.4x | XXX | XXX | XXX |
EV/FCF | n/a | XXX | -0.6x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialQlife Holding's revenue per employee in the last FY averaged $0K, while opex per employee averaged $0.1M for the same period.
Qlife Holding's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Qlife Holding's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Qlife Holding and other 12K+ public compsLTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
---|---|---|---|---|---|---|
Revenue Growth | n/a | XXX | n/a | XXX | XXX | XXX |
EBITDA Margin | n/a | XXX | -33236% | XXX | XXX | XXX |
EBITDA Growth | n/a | XXX | n/a | XXX | XXX | XXX |
Rule of 40 | n/a | XXX | n/a | XXX | XXX | XXX |
Bessemer Rule of X | XXX | XXX | n/a | XXX | XXX | XXX |
Revenue per Employee | XXX | XXX | $0K | XXX | XXX | XXX |
Opex per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
Opex to Revenue | XXX | XXX | 34787% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
EV/Revenue | EV/EBITDA | |||||
---|---|---|---|---|---|---|
2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
Philips | XXX | XXX | XXX | XXX | XXX | XXX |
Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Qlife Holding acquired XXX companies to date.
Last acquisition by Qlife Holding was XXXXXXXX, XXXXX XXXXX XXXXXX . Qlife Holding acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiplesAcquired Company | EV | EV/Revenue | EV/EBITDA |
---|---|---|---|
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free TrialWhen was Qlife Holding founded? | Qlife Holding was founded in 2019. |
Where is Qlife Holding headquartered? | Qlife Holding is headquartered in Sweden. |
How many employees does Qlife Holding have? | As of today, Qlife Holding has 35 employees. |
Is Qlife Holding publicy listed? | Yes, Qlife Holding is a public company listed on STO. |
What is the stock symbol of Qlife Holding? | Qlife Holding trades under QLIFE ticker. |
When did Qlife Holding go public? | Qlife Holding went public in 2020. |
Who are competitors of Qlife Holding? | Similar companies to Qlife Holding include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
What is the current market cap of Qlife Holding? | Qlife Holding's current market cap is $2.6M |
Is Qlife Holding profitable? | Yes, Qlife Holding is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.